Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE1C | Q14123 | 3/20 | 0.35 |
| ▸ | PDE9A | O76083 | 2/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.33 |
| ▸ | SQOR | Q9Y6N5 | 2/20 | 0.32 |
| ▸ | PDE5A | O76074 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21396590 | 0.92 | PDE1C (0.34) | PDE1CPDE9APTGDR2PDE5AKDM4E | |
| SCHEMBL21377984 | 0.92 | PDE9A (0.32) | PDE1CPDE9ASQORCYP11B2 | |
| SCHEMBL21377935 | 0.91 | PDE9A (0.31) | PDE1CPDE9ACYP11B2 | |
| SCHEMBL21377923 | 0.89 | PDE9A (0.32) | PDE1CPDE9ASQORCYP11B2 | |
| SCHEMBL21397178 | 0.89 | PDE9A (0.34) | PDE1CPDE9APTGDR2KDM4EALDH1A1 | |
| SCHEMBL21378013 | 0.88 | PDE9A (0.32) | PDE1CPDE9ANPY5RCYP11B2 | |
| SCHEMBL21396837 | 0.88 | TRPV1 (0.33) | PDE1CPDE9A | |
| SCHEMBL21378022 | 0.85 | PTGDR2 (0.34) | PTGDR2 | |
| SCHEMBL21396594 | 0.82 | CYP11B2 (0.30) | CYP11B2 | |
| SCHEMBL21396591 | 0.82 | CYP11B2 (0.30) | CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-03-21 | — | — | US | disclosed |
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux North America, Inc. | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | PDE1C 4875/4885PDE9A 4069/4885PTGDR2 3664/4885 |
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | PDE1C 4875/4885PDE9A 4069/4885PTGDR2 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.